Allegro Biotech

Allegro was founded in 2021 with the ultimate vision to augment humanity and prolong life, engineering the body atom-by-atom, blending nanotech and biotech. The company developed a promising nanotechnology platform to build therapeutic nanoparticles for orthopaedics, neuroscience, and chronic degenerative diseases. Allegro brings Xyletra to the market, the world's first disease-modifying treatment for osteoarthritis, which stops the degenerative process and alleviates pain with a year-long effect on a single shot administration.

Domain

allegro.bio

Country

Belgium

Employees

11-50

Last Funding

$2.4M

Founded

2021

Frequently Asked Questions

What technologies does Allegro Biotech use?+

Allegro Biotech uses 15 technologies including aThemes Sydney, Google Analytics, Google Tag Manager.

What industry is Allegro Biotech in?+

Allegro Biotech operates in the Biotechnology industry.

Where is Allegro Biotech based?+

Allegro Biotech is headquartered in Belgium.

Need this data at scale?

Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.

Browse Datasets

Data last updated: June 2026